Product Name :
QNZ (EVP4593)
CAS No.:
545380-34-5
Purity :
> 98%
Shipping:
Shipped on dry ice.
Storage :
Powder: -20 °C, 3 years; 4 °C, 2 yearsIn solvent: -80 °C, 6 months; -20 °C, 1 month
SMILES:
NC1=CC2=C(NCCC3=CC=C(OC4=CC=CC=C4)C=C3)N=CN=C2C=C1
Product Description :
QNZ (EVP4593) shows potent inhibitory activity toward both NF-κB activation and TNF-α production with IC50 of 11 nM and 7 nM in Jurkat T cells, respectively.
Formula:
C22H20N4O
Molecular Weight :
356.42
Synonyms:
Additional Information:
|CAS No. 545380-34-5 ; |Formula C22H20N4O ; |Molecular Weight 356.42 ; |SMILES NC1=CC2=C(NCCC3=CC=C(OC4=CC=CC=C4)C=C3)N=CN=C2C=C1 ; |Target NFkB ; |Product Description QNZ (EVP4593) shows potent inhibitory activity toward both NF-κB activation and TNF-α production with IC50 of 11 nM and 7 nM in Jurkat T cells, respectively.{{NNZ 2591} web|{NNZ 2591} Technical Information|{NNZ 2591} Data Sheet|{NNZ 2591} supplier|{NNZ 2591} Epigenetic Reader Domain} ; |Purity > 98% ; |Shipping Shipped on dry ice.{{Pembrolizumab (anti-PD-1)} web|{Pembrolizumab (anti-PD-1)} PD-1/PD-L1|{Pembrolizumab (anti-PD-1)} Purity & Documentation|{Pembrolizumab (anti-PD-1)} In stock|{Pembrolizumab (anti-PD-1)} custom synthesis|{Pembrolizumab (anti-PD-1)} Cancer} ; |Storage Powder: -20 °C, 3 years; 4 °C, 2 yearsIn solvent: -80 °C, 6 months; -20 °C, 1 month ; |Solubility Overview Soluble in DMSO